Chromium Clinical Trials

• Chromium Effects in Impaired Glucose Tolerance
  ClinicalTrials.gov Identifier: NCT00067626 - Active, not recruiting
  Obesity
  
• To Determine If Chromium Nicotinate Supplementation at 400ug/Day for 16 Weeks Will Improve Insulin Resistance in HIV Patients with Metabolic Abnormalities
  ClinicalTrials.gov Identifier: NCT00152893 - Recruiting
  HIV; blood sugar > 6.1 mmol/l; triglycerides > 2 mmol/l; total cholesterol > 5.5 mmol/l or HDL < 0.9 mmol/l
  
• Cobalt Chromium Stent With Antiproliferative for Restenosis II Trial COSTAR II Trial
  ClinicalTrials.gov Identifier: NCT00165035 - Active, not recruiting
  Coronary Disease
  
• Effects of Chromium Supplementation on Parameters of the Metabolic Syndrome in Patients with Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00145093 - Completed
  Diabetes Mellitus, Type 2
  
• Effect of Chromium Picolinate on Insulin Sensitivity in Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00398853 - Recruiting
  Type 2 Diabetes
  
• Use of a Nutritional Supplement to Treat Diabetic Symptoms in HIV Infected Adults
  ClinicalTrials.gov Identifier: NCT00109746 - Recruiting
  Insulin Resistance; HIV Infections; Diabetes Mellitus
  
• Chromium and Insulin Action
  ClinicalTrials.gov Identifier: NCT00283777 - Completed
  Type 2 Diabetes
  
• Effects of Chromium Picolinate on Food Intake
  ClinicalTrials.gov Identifier: NCT00477854 - Completed
  Obesity; Atypical Depression
  
• Efficacy and Safety Study of Chromium Picolinate + Biotin on Glucose and Cholesterol Control in T2DM
  ClinicalTrials.gov Identifier: NCT00289354 - Completed
  Diabetes Mellitus, Type 2
  
• Chromium Picolinate for the Treatment of Metabolic Syndrome
  ClinicalTrials.gov Identifier: NCT00128154 - Completed
  Metabolic Syndrome X; Prediabetic State; Insulin Resistance; Obesity; Metabolic Diseases
  
• A 30 Day Acute Efficacy and Safety Study of Chromium Picolinate + Biotin on Glycemic Control in Overweight or Obese Subjects With T2DM
  ClinicalTrials.gov Identifier: NCT00308451 - Completed
  Diabetes Mellitus, Type 2
  
• Pilot Trial of Chromium-Metformin Combination in Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00332085 - Terminated
  Type 2 Diabetes